Nicholas Opalich

Nicholas Opalich stands out as a distinguished leader in the pharmaceutical industry, primarily based in Northeast Ohio. With an impressive career spanning more than 25 years, he has become known for his profound expertise and experience across various facets of the field, particularly in the realms of mergers and acquisitions. His journey in the pharmaceutical landscape has seen him take on significant roles in executive leadership, where he honed his skills in hospice pharmaceutical claims processing, pharmacy benefits, and drug manufacturing. This path led him to specialize in hospice and palliative care pharmacy operations, as well as in developing mail-order pharmacy systems, specialty infusion services, pharmaceutical procurement models, and innovative medication delivery channels. He is the new Founder & CEO of HospiceChoice Rx at the National Hospice and Palliative Care Organization (NHPCO). Visit www.nhpco.org.

Nicholas's leadership prowess has not only driven numerous companies to achieve successful valuations but has also seen him mentor teams across diverse operational areas. These include hospice pharmacy operations, specialty medical benefit management, and a wide array of business development and marketing disciplines. His academic foundation was laid at David N. Myers University in Cleveland, Ohio, where he earned bachelor's degrees in pharmacy and business management, fueling his dual expertise in both the technical and administrative aspects of the industry.

Beyond his professional accomplishments, Nick dedicates himself to philanthropy and volunteer work, supporting causes such as animal welfare, poverty alleviation, public health, and homelessness. His personal life reflects a passion for family, football, sailing, and wrestling, showcasing a well-rounded character that extends beyond his professional pursuits.

As the Founder and CEO of HospiceChoice Rx, he currently spearheads a pharmacy benefit manager that emphasizes cost-effective administration and patient-centric care, primarily for hospice providers. This venture, launched in 2023, highlights his ongoing commitment to enhancing healthcare delivery systems.

Nick Opalich's career trajectory includes founding and leading companies like OPSIA and OPSIC, which evolved into Continental Health Care, a powerhouse in organ and bone marrow transplant services and pharmaceutical distribution. Later, as the brain behind Strategica Health Partners, he further cemented his legacy in the healthcare consultancy domain, providing strategic guidance to a slew of high-profile clients and healthcare companies. His tenure at Strategica, concluding in 2013, left an indelible mark on the industry, with Opalich continuing to influence the sector as a managing partner at the firm.